OPRX - OptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01 revenue of $13M beats by $0.64M
2023-05-10 16:07:01 ET
- OptimizeRx press release ( NASDAQ: OPRX ): Q1 Non-GAAP EPS of -$0.09 misses by $0.01 .
- Revenue of $13M (-5.3% Y/Y) beats by $0.64M .
- Gross profit in the first quarter of 2023 decreased 8% year-over-year to $7.4 million, from $8.1 million during the first quarter of 2022.
- Cash, cash equivalents and short-term investments totaled $73.7 million as of March 31, 2023 as compared to $74.1 million as of December 31, 2022.
-
2023 Financial OutlookThe Company is reaffirming its full year financial outlook for fiscal 2023 for net revenue to increase at least 10% year-over-year, and gross margins to be between 58% and 62%.
For further details see:
OptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64M